These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348 [TBL] [Abstract][Full Text] [Related]
5. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation. Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854 [TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma. Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826 [TBL] [Abstract][Full Text] [Related]
7. Metastatic melanoma in the eye and orbit. Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536 [TBL] [Abstract][Full Text] [Related]
8. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679 [TBL] [Abstract][Full Text] [Related]
9. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine. Melichar B; Voboril Z; Lojík M; Krajina A Hepatogastroenterology; 2009; 56(93):1157-62. PubMed ID: 19760961 [TBL] [Abstract][Full Text] [Related]
11. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L Clin Cancer Res; 2006 Feb; 12(4):1383-91. PubMed ID: 16489097 [TBL] [Abstract][Full Text] [Related]
12. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis. Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554 [TBL] [Abstract][Full Text] [Related]
13. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415 [TBL] [Abstract][Full Text] [Related]
14. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas. Ma D; Niederkorn JY Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065 [TBL] [Abstract][Full Text] [Related]
15. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma. Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492 [TBL] [Abstract][Full Text] [Related]
16. [Risk factors of extraocular spread after local treatment of uveal melanoma]. Neroev VV; Saakian SV; Amirian AG; Val'skiĭ VV Vestn Oftalmol; 2011; 127(2):21-5. PubMed ID: 21721267 [TBL] [Abstract][Full Text] [Related]
17. Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute. Höcht S; Bechrakis NE; Nausner M; Kreusel KM; Kluge H; Heese J; Heufelder J; Cordini D; Homeyer H; Fuchs H; Martus P; Foerster MH; Wiegel T; Hinkelbein W Strahlenther Onkol; 2004 Jul; 180(7):419-24. PubMed ID: 15241529 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in 1,521 melanoma patients with distant metastases. Barth A; Wanek LA; Morton DL J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677 [TBL] [Abstract][Full Text] [Related]
19. Long-term survival of uveal melanoma patients after surgery for liver metastases. Frenkel S; Nir I; Hendler K; Lotem M; Eid A; Jurim O; Pe'er J Br J Ophthalmol; 2009 Aug; 93(8):1042-6. PubMed ID: 19429579 [TBL] [Abstract][Full Text] [Related]
20. Osteopontin and 'melanoma inhibitory activity': comparison of two serological tumor markers in metastatic uveal melanoma patients. Haritoglou I; Wolf A; Maier T; Haritoglou C; Hein R; Schaller UC Ophthalmologica; 2009; 223(4):239-43. PubMed ID: 19270465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]